Wealth Enhancement Advisory Services LLC Has $44.79 Million Stake in Danaher Corporation $DHR

Wealth Enhancement Advisory Services LLC increased its position in shares of Danaher Corporation (NYSE:DHR) by 1.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 214,555 shares of the conglomerate’s stock after purchasing an additional 3,727 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Danaher were worth $44,793,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. WFA of San Diego LLC acquired a new position in shares of Danaher in the second quarter valued at about $26,000. Howard Hughes Medical Institute bought a new position in shares of Danaher during the second quarter worth approximately $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher in the third quarter valued at approximately $28,000. Red Tortoise LLC boosted its stake in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after buying an additional 98 shares during the period. Finally, Tripletail Wealth Management LLC bought a new position in Danaher during the 3rd quarter worth $31,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on DHR. TD Cowen upped their price target on shares of Danaher from $260.00 to $270.00 and gave the stock a “buy” rating in a report on Wednesday, January 7th. Robert W. Baird set a $247.00 price objective on shares of Danaher in a research report on Wednesday, October 22nd. Morgan Stanley started coverage on shares of Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 target price on the stock. Argus set a $265.00 price target on Danaher in a research note on Wednesday, January 14th. Finally, JPMorgan Chase & Co. boosted their price objective on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Twenty-one equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $251.87.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 21,776 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares in the company, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 30,248 shares of company stock worth $6,609,663. Insiders own 11.20% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $234.32 on Wednesday. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23. The company has a market cap of $165.51 billion, a P/E ratio of 48.31, a PEG ratio of 4.20 and a beta of 0.89. The company has a fifty day simple moving average of $229.17 and a 200 day simple moving average of $212.44. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the firm earned $1.71 EPS. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. Sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a yield of 0.5%. Danaher’s dividend payout ratio is presently 26.39%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.